A real-world study to evaluate the safety and efficacy of three injectable neurokinin-1 receptor antagonist formulations for the prevention of chemotherapy-induced nausea and vomiting in cancer patients.
George DranitsarisMehdi MoeziKate DobsonRobert PhelanSibel BlauPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
In this real-world analysis, patients receiving CINVANTI® had a reduced need for CINV rescue therapy and a numerically lower incidence of infusion reactions.